CA1098035A - Traduction non-disponible - Google Patents

Traduction non-disponible

Info

Publication number
CA1098035A
CA1098035A CA301,259A CA301259A CA1098035A CA 1098035 A CA1098035 A CA 1098035A CA 301259 A CA301259 A CA 301259A CA 1098035 A CA1098035 A CA 1098035A
Authority
CA
Canada
Prior art keywords
glaucine
active compound
composition according
hydrobromide
dosage unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA301,259A
Other languages
English (en)
Inventor
Alfred G. Maasbol
Alexander K. Sim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karl O Helm AG
Original Assignee
Karl O Helm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2717001A external-priority patent/DE2717001C2/de
Priority claimed from DE2717062A external-priority patent/DE2717062C2/de
Application filed by Karl O Helm AG filed Critical Karl O Helm AG
Application granted granted Critical
Publication of CA1098035A publication Critical patent/CA1098035A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CA301,259A 1977-04-18 1978-04-17 Traduction non-disponible Expired CA1098035A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEP2717062.3 1977-04-18
DEP2717001.0 1977-04-18
DE2717001A DE2717001C2 (de) 1977-04-18 1977-04-18 Arzneimittel mit antithrombotischer Wirkung
DE2717062A DE2717062C2 (de) 1977-04-18 1977-04-18 Arzneimittel mit antitussiver Wirkung

Publications (1)

Publication Number Publication Date
CA1098035A true CA1098035A (fr) 1981-03-24

Family

ID=25771874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA301,259A Expired CA1098035A (fr) 1977-04-18 1978-04-17 Traduction non-disponible

Country Status (7)

Country Link
JP (1) JPS53130437A (fr)
AU (1) AU520608B2 (fr)
CA (1) CA1098035A (fr)
FR (1) FR2387652A1 (fr)
GB (1) GB1587378A (fr)
IT (1) IT1104846B (fr)
NL (1) NL7803601A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645459A (en) * 1979-09-20 1981-04-25 Otsuka Pharmaceut Co Ltd Cyclic amine
FR2843963B1 (fr) * 2002-08-30 2004-10-22 Sederma Sa Nouvelles molecules derivees de la noraporphine

Also Published As

Publication number Publication date
IT1104846B (it) 1985-10-28
JPS53130437A (en) 1978-11-14
AU3519878A (en) 1979-10-25
AU520608B2 (en) 1982-02-11
NL7803601A (nl) 1978-10-20
IT7848932A0 (it) 1978-04-17
FR2387652B1 (fr) 1982-04-23
GB1587378A (en) 1981-04-01
FR2387652A1 (fr) 1978-11-17

Similar Documents

Publication Publication Date Title
US5223541A (en) Tramadol n-oxide material, enantiomers and compositions thereof, and their use
RU2409365C2 (ru) ПРИМЕНЕНИЕ 3,11b-ЦИС-ДИГИДРОТЕТРАБЕНАЗИНА ДЛЯ ЛЕЧЕНИЯ СИМПТОМОВ БОЛЕЗНИ ГЕНТИНГТОНА
JP6091426B2 (ja) 鎮痛剤として有用な新規モルフィナン類
KR0172596B1 (ko) 진해제로서의 엔도에테노/엔도에타노-에폭시모르피난 유도체의 (+)-이성질체
US4528289A (en) Corynantheine derivates, processes for their preparation, and their use
CA1098035A (fr) Traduction non-disponible
JPH05500822A (ja) 経口的に活性な非中毒性鎮痛薬
US4279914A (en) Thrombocyte aggregation inhibiting composition and methods
US4370331A (en) L-Glaucine containing composition for cough relief
WO1995021827A1 (fr) Nouveau compose du type aconitine, agent antipyretique, analgesique et anti-inflammatoire
US5804589A (en) Use of N-cyclohexyl benzamides for treating bowel disorders
GB2201676A (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
JPS63275583A (ja) 新規なアコニチン系化合物およびそれらを有効成分とする鎮痛・抗炎症剤
US3248292A (en) Pharmaceutically active dimethoxyquinazolines
IE47223B1 (en) Anti-tussic or anti-thrombotic pharmaceutical compositions and their preparation
US7629355B2 (en) Treatment of chemical dependency with substantially nonaddicting normorphine and norcodeine derivatives
US4183939A (en) Glaucine analgesic method
DE69619156T2 (de) Verwendung von alpha-Aminomethyl-3,4-dichlorbenzylthioaceamiden zur Herstellung eines dopaminwiederergreifungshemmenden Medikaments sowie Verbindungen zur Verwendung derselben
CA1331994C (fr) (+)-1-((3,4,5-trimethoxy)-benzyloxymethyl)-1-phenyl-n,n- propylamine, procede d'obtention et son utilisation et son utilisation en therapeutique
FI68812C (fi) Foerfarande foer framstaellning av terapeutiskt effektiva 1- och d,1-glausinlactatsalter
CA1220200A (fr) Procede de preparation d'halomethylates de levallorphan et composes pharmaceutiques les contenant et ayant une action inhibitrice des opiaces
US3073741A (en) Antitussive composition
US3328245A (en) Methods of use of tetrahydroisoquinoline antitussive
US4265912A (en) Glaucine lactate salts
CA1337424C (fr) Composes anitumeur extraits d'une eponge marine du genre dercitus

Legal Events

Date Code Title Description
MKEX Expiry